glp-1 drugs and fatty liver Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) for the management of nonalcoholic disease (NAFLD): A systematic review - Lv - 2020 - Endocrinology, Diabetes & Metabolism SGLT-2 inhibitors and GLP-1 receptor
Description
GLP-1R regulation of food intake The reduction in body weight induced by GLP-1R agonists is largely attributed to a reduction in food intake
In DELIGHT, the combination of saxagliptin and dapagliflozin showed potentially additive but marginal albuminuria-lowering effects in T2D subjects (Pollock et al., 2019)
Available from: Karagiannis T, Tsapas A, Athanasiadou E, Avgerinos I, Liakos A, Matthews DR et al (2021) GLP-1 receptor agonists and SGLT2 inhibitors for older people with type 2 diabetes: a systematic review and meta-analysis
Diabetes Care 40 , 161163 (2017)
2) Average weekly craving, average drinks per day, drinks per drinking day, number of heavy drinking days, and number of drinking vs abstinent days measured with daily self-report logs
Typically, bariatric procedures are covered if the patients meet ASMBS 2022 eligibility criteria
